Transcranial Color-coded Sonography for the Diagnosis of Parkinson's Disease

Abstract

Abstract:

Abstract】 Parkinson's disease is a progressive neurological disorder, which results from the degeneration of dopamine-producing cells in the substantia nigra (SN). Clinical symptoms typically include static tremor, bradykinesia, myotonia, and postural instability. However, clinical features in the early stages of Parkinson's disease are atypical. Therefore, it is important to develop a diagnostic tool aimed to recognize the early stages of Parkinson's disease. Transcranial color-coded sonography as a non-invasive technology has become an important instrument in the diagnosis of Parkinson's disease and in the differential diagnosis of Parkinsonism. Above all, transcranial colorcoded sonography has the capability of detecting substantia nigra hyperechogenicity and shows stenosis of vessels, which plays an important role in diagonosing Parkinson's disease in its early stages and differentiating Parkinson's disease and vascular parkinsonism. The main purpose of the current article is to summarize the significance of transcranial color-coded sonography in the diagnosis and differential diagnosis of Parkinson's disease.

Key words: Parkinson's disease; Transcranial sonography; Diagnosis

摘要：

【摘要】帕金森病是一种由于黑质的多巴胺细胞变性导致的一种神经系统退行性疾病。临床典型症状包括静止性震颤、运动迟缓、肌强直和姿势障碍。然而，帕金森病的早期阶段症状并不典型。因此发展一种早期诊断帕金森病的手段是非常必要的。经颅彩色多普勒超声作为一种非侵入性的技术，已成为帕金森病的诊断及与帕金森综合征鉴别诊断的重要工具。最重要的是，经颅彩色多普勒超声不仅能够探测黑质的高回声，同时能够检测到血管的狭窄程度，是早期诊断帕金森病及能够鉴别诊断血管性帕金森综合征的关键。

关键词: 帕金森病; 经颅超声; 诊断

XU Xiao-Yan*, SONG Xiao-Nan, XING Ying-Qi.. Transcranial Color-coded Sonography for the Diagnosis of Parkinson's Disease[J]. Chinese Journal of Stroke, 2014, 9(03): 204-209.

许晓燕1，宋晓南1，邢英琦2. 经颅彩色多普勒超声对帕金森病的诊断
价值[J]. 中国卒中杂志, 2014, 9(03): 204-209.

References

参考文献

1 贾建平, 崔丽英. 神经病学[M]. 第6版. 北京:人民卫生

出版社, 2008:273-274.

2 Tateishi Y, Iguchi Y, Kimura K, et al. Contrastenhanced

transcranial color-coded duplex sonography

criteria for basilar artery stenosis[J]. J Neuroimaging,

2008, 18:407-410.

3 Walter U, Behnke S, Eyding J, et al. Transcranial brain

parenchyma sonography in movement disorders:State

of the art[J]. Ultrasound Med Biol, 2007, 33:15-25.

4 邱会卿, 顾平, 樊文峰. 经颅脑实质超声诊断帕金病的

临床应用[J]. 临床误诊误治, 2011, 24:92-94.

5 Sastre-Bataller I, Vázquez JF, Martínez-Torres I, et

al. Mesencephalic area measured by transcranial

sonog r aphy i n t he d i f fe r e nt i a l d i ag nosi s of

parkinsonism[J]. Parkinsonism Relat Disord, 2013,

19:732-736.

6 Bouwma n s AE, Vl a a r AM, Me s s WH, e t a l.

Specificity and sensitivity of transcranial sonography

of the substantia nigra in the diagnosis of Parkinson's

disease:prospective cohort study in 196 patients[J].

BMJ Open, 2013, 3:pii:e002613.

7 Weise D, Lorenz R, Schliesser M, et al. Substantia

nigra echogenicity:A structural correlate of functional

impairment of the dopaminergic striatal projection in

Parkinson's disease[J]. Mov Disord, 2009, 24:1669-1675.

8 Berg D, Godau J, Walter U. Transcranial sonography

in movement disorders[J]. Lancet Neurol, 2008,

7:1044-1055.

9 Gaenslen A, Unmuth B, Godau J, et al. The specificity

and sensitivity of transcranial ultrasound in the

differential diagnosis of Parkinson's disease:a

prospective blinded study[J]. Lancet Neurol, 2008,

7:417-424.

10 Mehnert S, Reuter I, Schepp K, et al. Transcranial

sonography for diagnosis of Parkinson's disease[J].

BMC Neurol, 2010, 10:9.

11 Huang YW, Jeng JS, Tsai CF, et al. Transcranial

imaging of substantia nigra hyperechogenicity in

a Taiwanese cohort of Parkinson's disease[J]. Mov

Disord, 2007, 22:550-555.

12 Walter U, Klein C, Hilker R, et al. Brain parenchyma

sonography detects preclinical parkinsonism[J]. Mov

Disord, 2004, 19:1445-1449.

13 Walter U, Dressler D, Probst T, et al. Transcranial

brain sonography findings in discriminating between

parkinsonism and idiopathic Parkinson disease[J].

Arch Neurol, 2007, 64:1635-1640.

14 Behnke S, Berg D, Naumann M, et al. Differentiation

of Parkinson's disease and atypical parkinsonian

syndromes by transcranial ultrasound[J]. J Neurol

Neurosurg Psychiatry, 2005, 76:423-425.

15 Okawa M, Miwa H, Kajimoto Y, et al. Transcranial

sonography of the substantia nigra in Japanese

pat ient s with Pa rkinson's disease or at y pical

parkinsonism:clinical potential and limitations[J].

Intern Med, 2007, 46:1527-1531.

16 Budisic M, Trkanjec Z, Bosnjak J, et al. Distinguishing

Parkinson's disease and essential t remor with

transcranial sonography[J]. Acta Neurol Scand, 2009,

119:17-21.

17 Venegas-Francke P. Transcranial sonography in the

discrimination of Parkinson's disease versus vascular

parkinsonism[J]. Int Rev Neurobiol, 2010, 90:147-156.

18 Vlaar AM, de Nijs T, van Kroonenburgh MJ, et al.

The predictive value of transcranial duplex sonography

for the clinical diagnosis in undiagnosed parkinsonian

syndromes:comparison with SPECT scans[J]. BMC

Neurol, 2008, 8:42.

19 Zecca L, Berg D, Arzberger T, et al. In vivo detection

of iron and neuromelanin by transcranial sonography:a

new approach for early detection of substantia nigra

damage[J]. Mov Disord, 2005, 20:1278-1285.

20 Niehaus L, Boelmans K. Diagnosis of Parkinson's

disease-transcranial sonography in relation to MRI[J].

Int Rev Neurobiol, 2010, 90:63-79.

21 Casjens S, Eckert A, Woitalla D, et al. Diagnostic

value of the impairment of olfaction in Parkinson's

disease[J]. PLoS One, 2013, 8:e64735.

22 李伟, 冯涛, 王拥军, 等. 急性美多巴反应试验诊断

帕金森病的灵敏度及特异度研究[J]. 临床内科杂志,

2008, 25:603-605.

23 张丽娜, 朱海峰, 秦荣凤, 等. 帕金森病早期诊断的临

床研究[J]. 中国医药指南, 2012, 10:46-47.

24 Godau J, Wevers AK, Gaenslen A, et al. Sonographic abnormalities of brainstem structures in restless legs

syndrome[J]. Sleep Med, 2008, 9:782-789.

25 Tsai CF, Huang YW, Yip PK. Transcranial color-coded

sonography helps differentiation between idiopathic

Parkinson's disease and vascular parkinsonism[J]. J

Neurol, 2007, 254:501-507.

26 Sakalauskas A, Lukoševi ius A, Lau kait K, et al.

Automated segmentation of transcranial sonographic

images in the diagnostics of Parkinson's disease[J].

Ultrasonics, 2013, 53:111-121.

[1]	CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.
[2]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[3]	SHAN Kai, ZHAO Meng, WANG Chunjuan, LI Zixiao, WANG Xiaoyan. Exploration and Practice of Diagnosis and Treatment Models for Stroke and Comorbid Conditions [J]. Chinese Journal of Stroke, 2024, 19(8): 863-865.
[4]	LI Guangshuo, ZHAO Xingquan. Interpretation of the Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2023 [J]. Chinese Journal of Stroke, 2024, 19(8): 956-961.
[5]	WANG Yilong. Diagnosis and Treatment of Cerebral Small Vessel Disease and the Way of Future Exploration [J]. Chinese Journal of Stroke, 2024, 19(4): 363-374.
[6]	CHEN Weiqi, XU Jiajie, LU Yao, WANG Ling, CAO Jinyi, CHEN Hongbin, GUO Lei, LYU Yanchen, TANG Han, WANG Zan, XU Feifan, YAN Tingmeng, YING Yunqing, ZHONG Weiyi, ZHOU Rong, LU Zhengqi, CHENG Xin, WANG Yilong, Small Vessel Disease Branch of Chinese Stroke Association. Neuroimaging Diagnostic Criteria and Standardized Definition of Terms for Small Vessel Disease in China—Expert Consensus from the Chinese Stroke Association [J]. Chinese Journal of Stroke, 2024, 19(4): 376-404.
[7]	Neuro-Ophthalmology Society, Chinese Research Hospital Association, Neuro-Ophthalmology Society, Shaanxi Research Hospital Association. Expert Consensus on Clinical Diagnosis and Treatment of Central Retinal Artery Occlusion in China [J]. Chinese Journal of Stroke, 2024, 19(11): 1247-1267.
[8]	CHENG Xin, ZHONG Weiyi, DONG Yi, LI Qi, NI Wei, GU Hongqiu, GU Yuxiang, DONG Qiang, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Six Clinical Management of Subarachnoid Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(9): 1024-1029.
[9]	FAN Yuhua, DANG Chao, YU Jian, CHEN Hongbing, DUAN Jiangang, MO Dapeng, ZHU Wenhao, OUYANG Fubing, WANG Bo, ZENG Jinsheng, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Seven Clinical Management of Cerebral Venous Thrombosis [J]. Chinese Journal of Stroke, 2023, 18(9): 1030-1035.
[10]	XIONG Yunyun, WANG Yongjun. Chinese Studies Changed the National Clinical Guideline for Stroke for the United Kingdom and Ireland [J]. Chinese Journal of Stroke, 2023, 18(12): 1337-1342.
[11]	LIU Yonghui, YANG Kan, QIN Fubin, CHEN Wenwen, HE Tingting, HUANG Yadi. Progress of Headache due to Reversible Cerebral Vasoconstriction Syndrome [J]. Chinese Journal of Stroke, 2022, 17(05): 455-460.
[12]	LI Wen-Jun, LIU Cui-Cui, LIU Jun-Yan. The Value of High Resolution Vessel Wall Magnetic Resonance Imaging in the Etiological Diagnosis of Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(01): 39-44.
[13]	ZHANG Xi, SU Jun-Hui, JIN Ling-Jing, TENG Fei. Advance in Serum Biomarkers for Early Identification of Cerebral Infarction and Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2019, 14(04): 389-394.
[14]	DU Wan-Liang, WANG Yong-Jun. Cerebral Vascular Disease Related Headache [J]. Chinese Journal of Stroke, 2018, 13(03): 267-271.
[15]	GAO Shuo-Jun,ZHANG Xiang-Jian, ZHANG Pei-Pei. Research Progress of Diagnostic Biomarkers Related to Cerebral Infarction [J]. Chinese Journal of Stroke, 2017, 12(12): 1154-1157.